Taxotere
Taxotere is a chemotherapy drug that is designed and manufactured to treat breast cancer as an alternative to Paclitaxel.
Nature of the Lawsuit
The allegations against the manufacturer Sanofi-Aventis failed to warn patients of the increased risks of permanent hair loss (alopecia). The manufacturer warned users in other countries of this risk and therefore patients were unable to make an informed decision regarding the medication and its alternatives.